Amends TCA Title 8; Title 56; Title 63; Title 68 and Title 71.
Tennessee SB1382, now incorporated into House Bill 858, prohibits health benefit plans from requiring step therapy for approved prescription drugs for patients diagnosed with stage 4 advanced metastatic cancer or blood cancer. It affects health benefit plans and treating healthcare providers, mandating that providers submit annual reports on treatment cases and survival rates. Key provisions include defining "approved prescription drug," exempting state employee insurance plans, and allowing the requirement of AB-rated generics before branded drugs.
Tennessee SB1382, now incorporated into House Bill 858, prohibits health benefit plans from requiring step therapy for approved prescription drugs for patients diagnosed with stage 4 advanced metastatic cancer or blood cancer. It affects health benefit plans and treating healthcare providers, mandating that providers submit annual reports on treatment cases and survival rates. Key provisions include defining "approved prescription drug," exempting state employee insurance plans, and allowing the requirement of AB-rated generics before branded drugs.
Track Tennessee Legislation Like a Pro
Join hundreds of professionals using LegisGo to stay ahead of legislative changes.
Instant Alerts
Get notified when bills you track move through the legislature
AI Summaries
Understand complex legislation in seconds with AI-powered analysis
Full Access
All 132 legislators, committee schedules, and voting records